Home›People›Brian Lenz
BL

Brian Lenz

Chief financial officer at Bridge to Life.

ExecutiveDirectorPublic company
Updated Nov 8, 2026·Latest SEC filing Oct 21, 2026·Suggest an edit

About Brian Lenz

Brian Lenz is chief financial officer at Bridge to Life, which makes tools that preserve organs. He remains on its board. He had served there for two and a half years before his appointment. Across his CFO roles, he worked on acquisitions and licensing and helped move companies from research into profitable sales. Their market values rose from below $100 million to above $1 billion.

Before Bridge to Life, Lenz spent 12 years at ADMA Biologics as chief financial officer and general manager of its ADMA BioCenters subsidiary. Earlier, he was chief financial officer and chief operating officer at CorMedix, held CFO roles at other biotechnology companies, and began in audit at KPMG. His career includes more than 20 years of CFO leadership. He has raised more than $1 billion through equity and debt financing and helped take two companies public. He is a licensed CPA, earned a bachelor's degree from Rider University, and received an MBA from St. Joseph's University.

Experience

This experience comes from official bios, from Brian Lenz's profile and from SEC filings. For roles taken from filings, the years are when the filings name Brian Lenz in the role, so the role may have started earlier or lasted longer.

Bridge to Life Ltd. Current
Chief Financial Officer
member of the Board of Directors
2024 – Present · Duluth, GA
Bridge to Life supplies organ preservation products and perfusion systems to transplant organizations worldwide.
Adma Biologics, Inc.
EVP, CFO
Chief Financial Officer
2012 – 2024 · Public company (ADMA)
CorMedix Inc.
CFO, Treasurer & Secretary
CFO and COO
2010 – 2012 · Public company (CRMD)
Arno Therapeutics, Inc
CFO
2008 – 2010 · Public company (ARNI)
VioQuest Pharmaceuticals, Inc.
CFO and Treasurer
2003 – 2008 · Public company (VOQP)
Smiths Detection
Controller
2000 – 2003
ADMA BioCenters
General Manager
KPMG

Key Colleagues at Startups

The people Brian Lenz works with at each company, as listed on that company's latest Form D.

Bridge to Life Ltd. · Form D, Oct 21, 2026
DW
Don Webber
CEO and President
David Castiglioni
David Castiglioni
Chief Commercial Officer
MC
Mauricio Carvalho
VP Medical and Scientific Affairs

Sources

  1. SECBridge to Life Ltd. Form D, filed Oct 21, 2026
  2. SECForms 3, 4 and 5 filed by Brian Lenz (SEC filer 1283260)
  3. P1Bridge to Life CFO appointment release
  4. P2ADMA Biologics registration statement